Literature DB >> 29223475

Insights from clinical experience in treating IVF poor responders.

Kelly J Gonda1, Alice D Domar2, Norbert Gleicher3, Richard P Marrs4.   

Abstract

'Poor responders' is a term used to describe a subpopulation of IVF patients who do not respond well to ovarian stimulation with gonadotrophins. While there is no standard definition of a poor responder, these patients tend to be of advanced maternal age (≥40 years), have a history of poor ovarian response with conventional stimulation protocols, and/or have low ovarian reserve. Despite the heterogeneity of this patient group, there are characteristics and needs common to many poor responders that can be addressed through a holistic approach. Stimulation during the earlier stages of follicle maturation may help synchronize follicle development for improved response to later gonadotrophin stimulation, and supplementation with dehydroepiandrosterone or human growth hormone may promote early follicle development in poor responders. IVF protocols should be specifically tailored to poor responders to complement the patient's natural cycle. Because poor responders tend to have high levels of stress and anxiety, patients should receive psychological counselling and support, both prior to and during IVF cycles, to ensure optimal outcomes and improve patients' experience. It is important to set realistic expectations with poor responders and their partners to help patients make informed decisions and better manage their distress and anxiety.
Copyright © 2017. Published by Elsevier Ltd.

Entities:  

Keywords:  IVF; dehydroepiandrosterone; distress; ovarian stimulation; poor responders

Mesh:

Substances:

Year:  2017        PMID: 29223475     DOI: 10.1016/j.rbmo.2017.09.016

Source DB:  PubMed          Journal:  Reprod Biomed Online        ISSN: 1472-6483            Impact factor:   3.828


  7 in total

1.  Donor egg is the best second choice for many infertile couples: real progress in overcoming age-related fertility is not here yet.

Authors:  Reeva Makhijani; Daniel R Grow
Journal:  J Assist Reprod Genet       Date:  2020-07-11       Impact factor: 3.412

2.  Assessing the practice of LuPOR for poor responders: a prospective study evaluating follicular fluid cfDNA levels during natural IVF cycles.

Authors:  Sfakianoudis Konstantinos; Tsioulou Petroula; Maziotis Evangelos; Giannelou Polina; Glava Argyro; Grigoriadis Sokratis; Rapani Anna; Nezos Andrianos; Pantou Agni; Koutsilieris Michael; Pantos Konstantinos; Mastorakos George; Simopoulou Mara
Journal:  J Assist Reprod Genet       Date:  2020-03-27       Impact factor: 3.412

3.  Stop GnRH-Agonist Combined With Multiple-Dose GnRH-Antagonist Protocol for Patients With "Genuine" Poor Response Undergoing Controlled Ovarian Hyperstimulation for IVF.

Authors:  Raoul Orvieto; Michal Kirshenbaum; Valentina Galiano; Tal Elkan-Miller; Eran Zilberberg; Jigal Haas; Ravit Nahum
Journal:  Front Endocrinol (Lausanne)       Date:  2020-05-22       Impact factor: 5.555

Review 4.  What Is the Best Regimen for Ovarian Stimulation of Poor Responders in ART/IVF?

Authors:  Zeev Blumenfeld
Journal:  Front Endocrinol (Lausanne)       Date:  2020-04-17       Impact factor: 5.555

5.  Ovarian Follicular Growth through Intermittent Vaginal Gonadotropin Administration in Diminished Ovarian Reserve Women.

Authors:  Chao-Chin Hsu; Isabel Hsu; Li-Hsuan Lee; Rosie Hsu; Yuan-Shuo Hsueh; Chih-Ying Lin; Hui Hua Chang
Journal:  Pharmaceutics       Date:  2022-04-15       Impact factor: 6.525

6.  Cumulative live-birth, perinatal and obstetric outcomes for POSEIDON groups after IVF/ICSI cycles: a single-center retrospective study.

Authors:  Raed K Abdullah; Nenghui Liu; Yuhao Zhao; Yang Shuang; Zhang Shen; Hong Zeng; Jielei Wu
Journal:  Sci Rep       Date:  2020-07-16       Impact factor: 4.379

Review 7.  The Conundrum of Poor Ovarian Response: From Diagnosis to Treatment.

Authors:  Polina Giannelou; Mara Simopoulou; Sokratis Grigoriadis; Evangelos Makrakis; Adamantia Kontogeorgi; Agni Pantou; Dionysios Galatis; Theodoros Kalampokas; Panagiotis Bakas; Stamatis Bolaris; Konstantinos Pantos; Konstantinos Sfakianoudis
Journal:  Diagnostics (Basel)       Date:  2020-09-11
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.